title: Insulin is required for amino acid stimulation of dual pathways for translational control in skeletal muscle in the late-gestation ovine fetus.
abstract: During late gestation, amino acids and insulin promote skeletal muscle protein synthesis. However, the independent effects of amino acids and insulin on the regulation of mRNA translation initiation in the fetus are relatively unknown. The purpose of this study was to determine whether acute amino acid infusion in the late-gestation ovine fetus, with and without a simultaneous increase in fetal insulin concentration, activates translation initiation pathway(s) in skeletal muscle. Fetuses received saline (C), mixed amino acid infusion plus somatostatin infusion to suppress amino acid-stimulated fetal insulin secretion (AA+S), mixed amino acid infusion with concomitant physiological increase in fetal insulin (AA), or high-dose insulin infusion with euglycemia and euaminoacidemia (HI). After a 2-h infusion period, fetal skeletal muscle was harvested under in vivo steady-state conditions and frozen for quantification of proteins both upstream and downstream of mammalian target of rapamycin (mTOR). In the AA group, we found a threefold increase in ribosomal protein S6 kinase (p70(S6k)) and Erk1/2 phosphorylation; however, blocking the physiological rise in insulin with somatostatin in the AA+S group prevented this increase. In the HI group, Akt, Erk1/2, p70(S6k), and ribosomal protein S6 were highly phosphorylated and 4E-binding protein 1 (4E-BP1) associated with eukaryotic initiation factor (eIF)4E decreased by 30%. These data show that insulin is a significant regulator of intermediates involved in translation initiation in ovine fetal skeletal muscle. Furthermore, the effect of amino acids is dependent on a concomitant increase in fetal insulin concentrations, because amino acid infusion upregulates p70(S6k) and Erk only when amino acid-stimulated increase in insulin occurs.
authors.affiliation: UCD Perinatal Research Center, F441, 13243 East 23rd Ave., PO Box 6508, Aurora, CO 80045, USA. laura.brown@ucdenver.edu
authors.forename: Laura D
authors.initials: LD
authors.lastname: Brown
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Rozance
authors.forename: James S
authors.initials: JS
authors.lastname: Barry
authors.forename: Jacob E
authors.initials: JE
authors.lastname: Friedman
authors.forename: William W
authors.initials: WW
authors.lastname: Hay
mesh_terms: D000596:Amino Acids / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D015153:Blotting, Western; D039561:Eukaryotic Initiation Factor-4E / Q000378:metabolism; D005260:Female; D005333:Fetus; D006946:Hyperinsulinism / Q000378:metabolism; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D011247:Pregnancy; D014176:Protein Biosynthesis; D011494:Protein Kinases / Q000378:metabolism; D011897:Random Allocation; D019893:Ribosomal Protein S6 Kinases / Q000378:metabolism; D012756:Sheep; D013004:Somatostatin / Q000378:metabolism; D058570:TOR Serine-Threonine Kinases
chemical_list: D000596:Amino Acids; D039561:Eukaryotic Initiation Factor-4E; D007328:Insulin; D013004:Somatostatin; D011494:Protein Kinases; D019893:Ribosomal Protein S6 Kinases; D058570:TOR Serine-Threonine Kinases; D048052:Mitogen-Activated Protein Kinase 3